The hypertension drug, verapamil, activates Nrf2 by promoting p62-dependent autophagic Keap1 degradation and prevents acetaminophen-induced cytotoxicity

被引:31
作者
Lee, Da Hyun [1 ,2 ]
Park, Jeong Su [1 ]
Lee, Yu Seol [1 ]
Sung, Su Haeng [1 ]
Lee, Yong-ho [3 ]
Bae, Soo Han [1 ]
机构
[1] Yonsei Univ, Coll Med, Yonsei Biomed Res Inst, Severance Biomed Sci Inst, Seoul 03722, South Korea
[2] Yonsei Univ, Brain Korea PLUS Project Med Sci 21, Seoul 03722, South Korea
[3] Yonsei Univ, Div Endocrinol & Metab, Dept Internal Med, Coll Med, Seoul 03722, South Korea
基金
新加坡国家研究基金会;
关键词
APAP; Keap1; Nrf2; Oxidative stress; Verapamil; CALCIUM-CHANNEL BLOCKERS; NONALCOHOLIC STEATOHEPATITIS; INDUCED HEPATOTOXICITY; TRANSCRIPTION FACTOR; SELECTIVE AUTOPHAGY; OXIDATIVE STRESS; PATHWAY; MECHANISM; CELLS; MICE;
D O I
10.5483/BMBRep.2017.50.2.188
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nuclear factor erythroid 2-related factor 2 (Nrf2) provides a cellular defense against oxidative stress by inducing the expression of antioxidant and detoxification enzymes. The calcium antagonist, verapamil, is an FDA-approved drug prescribed for the treatment of hypertension. Here, we show that verapamil acts as a potent Nrf2 activator without causing cytotoxicity, through degradation of Kelch-like ECH-associated protein 1 (Keap1), a Nrf2 repressor. Furthermore, verapamil-induced Keap1 degradation is prominently mediated by a p62-dependent autophagic pathway. Correspondingly, verapamil protects cells from acetaminophen-induced oxidative damage through Nrf2 activation. These results demonstrated the underlying mechanisms for the protective role of verapamil against acetaminophen-induced cytotoxicity.
引用
收藏
页码:91 / 96
页数:6
相关论文
共 35 条
[1]   Sestrins Activate Nrf2 by Promoting p62-Dependent Autophagic Degradation of Keap1 and Prevent Oxidative Liver Damage [J].
Bae, Soo Han ;
Sung, Su Haeng ;
Oh, Sue Young ;
Lim, Jung Mi ;
Lee, Se Kyoung ;
Park, Young Nyun ;
Lee, Hye Eun ;
Kang, Dongmin ;
Rhee, Sue Goo .
CELL METABOLISM, 2013, 17 (01) :73-84
[2]   Nrf2: A Potential Target for New Therapeutics in Liver Disease [J].
Bataille, A. M. ;
Manautou, J. E. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 92 (03) :340-348
[3]   An important function of Nrf2 in combating oxidative stress: Detoxification of acetaminophen [J].
Chan, KM ;
Han, XD ;
Kan, YW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (08) :4611-4616
[4]   The hepatotoxic metabolite of acetaminophen directly activates the Keap1-Nrf2 cell defense system [J].
Copple, Ian M. ;
Goldring, Christopher E. ;
Jenkins, Rosslind E. ;
Chia, Alvin J. L. ;
Randle, Laura E. ;
Hayes, John D. ;
Kitteringham, Neil R. ;
Park, B. Kevin .
HEPATOLOGY, 2008, 48 (04) :1292-1301
[5]   Activation of hepatic Nrf2 in vivo by acetaminophen in CD-1 mice [J].
Goldring, CEP ;
Kitteringham, NR ;
Elsby, R ;
Randle, LE ;
Clement, YN ;
Williams, DP ;
McMahon, M ;
Hayes, JD ;
Itoh, K ;
Yamamoto, M ;
Park, BK .
HEPATOLOGY, 2004, 39 (05) :1267-1276
[6]   CALCIUM-METABOLISM IN UREMIC NEPHROCALCINOSIS - PREVENTIVE EFFECT OF VERAPAMIL [J].
GOLIGORSKY, MS ;
CHAIMOVITZ, C ;
RAPOPORT, J ;
GOLDSTEIN, J ;
KOL, R .
KIDNEY INTERNATIONAL, 1985, 27 (05) :774-779
[7]  
Hinson Jack A, 2010, Handb Exp Pharmacol, P369, DOI 10.1007/978-3-642-00663-0_12
[8]   Phosphorylation of p62 Activates the Keap1-Nrf2 Pathway during Selective Autophagy [J].
Ichimura, Yoshinobu ;
Waguri, Satoshi ;
Sou, Yu-shin ;
Kageyama, Shun ;
Hasegawa, Jun ;
Ishimura, Ryosuke ;
Saito, Tetsuya ;
Yang, Yinjie ;
Kouno, Tsuguka ;
Fukutomi, Toshiaki ;
Hoshii, Takayuki ;
Hirao, Atsushi ;
Takagi, Kenji ;
Mizushima, Tsunehiro ;
Motohashi, Hozumi ;
Lee, Myung-Shik ;
Yoshimori, Tamotsu ;
Tanaka, Keiji ;
Yamamoto, Masayuki ;
Komatsu, Masaaki .
MOLECULAR CELL, 2013, 51 (05) :618-631
[9]   Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain [J].
Itoh, K ;
Wakabayashi, N ;
Katoh, Y ;
Ishii, T ;
Igarashi, K ;
Engel, JD ;
Yamamoto, M .
GENES & DEVELOPMENT, 1999, 13 (01) :76-86
[10]   Discovery of the Negative Regulator of Nrf2, Keap1: A Historical Overview [J].
Itoh, Ken ;
Mimura, Junsei ;
Yamamoto, Masayuki .
ANTIOXIDANTS & REDOX SIGNALING, 2010, 13 (11) :1665-1678